Why Dollar Tree Shares Are Crumbling
Dollar Tree reported disappointing fiscal fourth-quarter results before the markets opened on Wednesday.
All Work
Chris Lange
Abercrombie & Fitch Keeps the Streak Alive
Abercrombie & Fitch released better than expected quarterly results before the markets opened on Wednesday.
Can Urban Outfitters Catch a Break?
Urban Outfitters shares fell after it reported better-than-expected fiscal fourth-quarter financial results late on Tuesday.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was mixed day for the broad U.S. markets, with all the major indices going positive and negative at some point during the day. At one point the Dow was down over 150 points,…
Can Abercrombie & Fitch Keep the Streak Alive?
Abercrombie & Fitch is set to report its fiscal fourth quarter financial results before the markets open on Wednesday.
What to Expect From Urban Outfitter Earnings
Urban Outfitters, which aced a tough holiday season, is scheduled to release its most recent quarterly results after the markets close on Tuesday.
Is It Finally Time to Buy Into Mylan?
Mylan has been through the ringer over the past couple of years, but by the looks of it, this stock could be turning around.
Why the Downside of Tariffs May Not Kill the Upside for US Steel Giants
24/7 Wall St. has tracked multiple stocks tied to steel and aluminum, and most of them saw impressive gains last week, and even into this week.
How Target Missed the Mark in Q4
Target released disappointing fiscal fourth-quarter financial results before the markets opened on Tuesday.
Monday’s Biggest Winners and Losers in the S&P 500
Monday started out as a down day for the broad U.S. markets, but as it went on everything recovered and the markets found themselves posting an impressive gain on the day. At one point…
Does Deutsche Bank Finally Have It Right on Valeant?
Valeant Pharmaceuticals saw its shares make a handy gain on Monday after Deutsche Bank upgraded the stock.
Why Dermira Shares Are Getting Crushed
Dermira watched its shares absolutely collapse early on Monday after the firm reported disappointing results from its late-stage trials in patients with acne vulgaris.
Why Clearside BioMedical Is Monday’s Biggest Winner
Clearside BioMedical saw its shares make an incredible gain to start the week after the firm announced positive topline results from its late-stage trial.
Lyft Looks to Pioneer the Future of Ride-Hailing
In a groundbreaking move early on Monday, the ride-hailing service Lyft is partnering with Allscripts Health Solutions to help hospitals and doctors’ offices schedule rides for patients who need them.
How Walmart Is Breaking Into Meal Kits
Walmart is taking a shot at meal kit providers like Blue Apron by offering meal kits and simpler “one-step meals” in over 250 stores.
Target, Costco and More Big Earnings Coming This Week
24/7 Wall St. has put together a preview of Target, Costco, Kroger and some of the other top companies reporting their latest results in the coming week.
Salesforce.com: Why Analysts and Investors Can’t Get Enough
The most recent earnings report only seems to prove that analysts and investors cannot get enough of Salesforce.com.
Major Biopharma Catalysts and FDA Events to Look For in March
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.
Friday’s Biggest Winners and Losers in the S&P 500
Friday started out as another bad day for the broad U.S. markets, but as it went on, everything seemed to turn around but not entirely. At one point the Dow was down 400 points,…
Dick’s Down as Sports Retail Disappoints
Dick’s Sporting Goods has been upfront in the news this week, after the company very publicly announced that it will halt sales of all assault-style and semi-automatic rifles.